Considering the significant correlation between high fibronectin levels and poor overall survival (OS) outcome in basal breast tumors, this suggested that fibronectin may represent a critical downstream regulator of the TGFβ/Smad3/COX-2 effects on cancer stemness. This evidence concerns the gene FN1 and breast neoplasm.